Related references
Note: Only part of the references are listed.Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect
Wei Du et al.
ONCOIMMUNOLOGY (2018)
Host-Derived Serine Protease Inhibitor 6 Provides Granzyme B-Independent Protection of Intestinal Epithelial Cells in Murine Graft-versus-Host Disease
Hemn Mohammadpour et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The effect of TnF-α on Regulatory T Cell Function in Graft-versus-Host Disease
Antonella Mancusi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma
Dae Seong Kim et al.
EBIOMEDICINE (2018)
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
Antonio Galleu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
Mathieu Leclerc et al.
BLOOD (2016)
Natural Killer Cells for Therapy of Leukemia
Garnet Suck et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation
Md Ashik Ullah et al.
FRONTIERS IN IMMUNOLOGY (2016)
B Cells in Chronic Graft-versus-Host Disease
Stefanie Sarantopoulos et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure
Jichun Chen et al.
BLOOD (2015)
Granzymes Regulate Proinflammatory Cytokine Responses
Annette C. Wensink et al.
JOURNAL OF IMMUNOLOGY (2015)
Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease
Wei Du et al.
JOURNAL OF IMMUNOLOGY (2015)
Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8+ T cells
Jennifer Theiss-Suennemann et al.
JOURNAL OF PATHOLOGY (2015)
Granzyme A Is Required for Regulatory T-Cell Mediated Prevention of Gastrointestinal Graft-versus-Host Disease
Sarvari Velaga et al.
PLOS ONE (2015)
TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
Martin Lelaidier et al.
ONCOTARGET (2015)
Granzyme B-induced mitochondrial ROS are required for apoptosis
G. Jacquemin et al.
CELL DEATH AND DIFFERENTIATION (2015)
Regulation of tumour necrosis factor signalling: live or let die
Dirk Brenner et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The biology of graft-versus-host disease: experimental systems instructing clinical practice
Kate A. Markey et al.
BLOOD (2014)
Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts
K. Mizrahi et al.
BONE MARROW TRANSPLANTATION (2014)
The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity
Hui Wang et al.
IMMUNOLOGICAL REVIEWS (2014)
Programmed Death-1 Pathway in Host Tissues Ameliorates Th17/Th1-Mediated Experimental Chronic Graft-versus-Host Disease
Hideaki Fujiwara et al.
JOURNAL OF IMMUNOLOGY (2014)
Current and emerging strategies for the prevention of graft-versus-host disease
Sung Won Choi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Depletion of Naive Lymphocytes with Fas Ligand Ex Vivo Prevents Graft-versus-Host Disease without Impairing T Cell Support of Engraftment or Graft-versus-Tumor Activity
Nadir Askenasy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality
Asim Saha et al.
BLOOD (2013)
Regulatory T Cells in Allogeneic Stem Cell Transplantation
Maria Michael et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease
Esma S. Yolcu et al.
EXPERIMENTAL HEMATOLOGY (2013)
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
Arnab Ghosh et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Granzyme B-Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect
Guanglin Bian et al.
JOURNAL OF IMMUNOLOGY (2013)
Graft-versus-Host Disease Impairs Vaccine Responses through Decreased CD4+ and CD8+ T Cell Proliferation and Increased Perforin-Mediated CD8+ T Cell Apoptosis
Christian M. Capitini et al.
JOURNAL OF IMMUNOLOGY (2013)
Adoptive Transfer of Tc1 or Tc17 Cells Elicits Antitumor Immunity against Established Melanoma through Distinct Mechanisms
Yu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Mouse T Cells Engineered to Display on Their Surface a Novel Form of FasL Protein Undergo Apoptosis When Stimulated With Alloantigens: Implications for Graft-Versus-Host Disease
E. S. Yolcu et al.
TRANSPLANTATION PROCEEDINGS (2013)
TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes
Sung W. Choi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
A quarter century of granzymes
C. L. Ewen et al.
CELL DEATH AND DIFFERENTIATION (2012)
A TLR5 Agonist Enhances CD8+ T Cell-Mediated Graft-versus-Tumor Effect without Exacerbating Graft-versus-Host Disease
Xilai Ding et al.
JOURNAL OF IMMUNOLOGY (2012)
IFN-γ Production by Allogeneic Foxp3+ Regulatory T Cells Is Essential for Preventing Experimental Graft-versus-Host Disease
Christian Koenecke et al.
JOURNAL OF IMMUNOLOGY (2012)
Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: A clinical analysis
Qiuling Wu et al.
LEUKEMIA RESEARCH (2012)
Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning
Samir Nusair et al.
TRANSPLANT IMMUNOLOGY (2012)
Multiple Single-Nucleotide Polymorphism-Based Risk Model for Clinical Outcomes After Allogeneic Stem-Cell Transplantation, Especially for Acute Graft-Versus-Host Disease
Dennis (Dong Hwan) Kim et al.
TRANSPLANTATION (2012)
Human regulatory T cells in allogeneic stem cell transplantation
Sya N. Ukena et al.
BLOOD (2011)
Implications of TNF-α in the pathogenesis and management of GVHD
John E. Levine
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
The Involvement of Epithelial Fas in a Human Model of Graft Versus Host Disease
Nicolas Ruffin et al.
TRANSPLANTATION (2011)
Granzyme B is not required for regulatory T cell-mediated suppression of graft-versus-host disease
Sheng F. Cai et al.
BLOOD (2010)
In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
Jaebok Choi et al.
BLOOD (2010)
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Janelle A. Olson et al.
BLOOD (2010)
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
Il-Kang Na et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
Jimmy A. Rotolo et al.
BLOOD (2009)
Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease
Niklas Beyersdorf et al.
BLOOD (2009)
Paradoxical effects of IFN-γ in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury
Hui Wang et al.
BLOOD (2009)
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network
Amin M. Alousi et al.
BLOOD (2009)
The role of B cells in the pathogenesis of graft-versus-host disease
Alexander Shimabukuro-Vornhagen et al.
BLOOD (2009)
Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand
Osnat Bohana-Kashtan et al.
JOURNAL OF IMMUNOLOGY (2009)
Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
Wendy Anne Boivin et al.
LABORATORY INVESTIGATION (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
CD95, BIM and T cell homeostasis
Philippe Bouillet et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Death by a thousand cuts: Granzyme pathways of programmed cell death
Dipanjan Chowdhury et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival
Sung W. Choi et al.
BLOOD (2008)
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
John E. Levine et al.
BLOOD (2008)
Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation
Shosaku Nomura et al.
TRANSPLANT IMMUNOLOGY (2007)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Islet allograft rejection by contact-dependent CD8+ T cells:: Perforin and FasL play alternate but obligatory roles
M. Sleater et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
Teresa Ramirez-Montagut et al.
JOURNAL OF IMMUNOLOGY (2007)
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity
Chiara Borsotti et al.
BLOOD (2007)
CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease
Christophe Deschaumes et al.
LABORATORY INVESTIGATION (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Ex vivo soluble Fas ligand treatment of donor cells to selectively reduce murine acute craft versus host disease
Robert W. Georgantas et al.
TRANSPLANTATION (2006)
TRAIL-induced cell death cooperates with IFN-γ activation in the graft-versus-tumor effect against colon tumors
K Tateishi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways
Z Zimmerman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease
Y Maeda et al.
BLOOD (2005)
The role of p53 and Fas in a model of acute murine graft-versus-host disease
S Yada et al.
JOURNAL OF IMMUNOLOGY (2005)
Donor T cells lacking Fas ligand, and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients
L Marks et al.
TRANSPLANTATION (2004)
Allogeneic transplantation of CD34+selected hematopoietic cells -: Clinical problems and current challenges
U Platzbecker et al.
LEUKEMIA & LYMPHOMA (2004)
Graft-versus-leukemia reactions in allogeneic chimeras
HJ Kolb et al.
BLOOD (2004)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
Tumor necrosis factor-α blockade for the treatment of acute GVHD
D Couriel et al.
BLOOD (2004)
Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning
TB Prigozhina et al.
EXPERIMENTAL HEMATOLOGY (2004)
Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression
G Socie et al.
BLOOD (2004)
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells
WJ Grossman et al.
BLOOD (2004)
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation
C Schmaltz et al.
BLOOD (2003)
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
JH Antin et al.
BLOOD (2002)
Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation
P Reddy et al.
BLOOD (2002)
Cytolytic pathways in haematopoietic stem-cell transplantation
MRM van den Brink et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis
P Reddy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease
C Wasem et al.
JOURNAL OF IMMUNOLOGY (2001)
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
KR Cooke et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect
C Schmaltz et al.
BLOOD (2001)
CD28-Specific antibody prevents graft-versus-host disease in mice
XZ Yu et al.
JOURNAL OF IMMUNOLOGY (2000)
Fas-deficient lpr mice are more susceptible to graft-versus-host disease
MRM van den Brink et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
